Brett Favre is one of the most recognizable names around the NFL. Favre has stayed quite vocal about his physical issues and persistent in discussing concussions. The former Green Bay Packers great is now taking the next step toward helping transform concussion treatment.
Brett Favre’s health since his retirement
Since stepping into retirement from the NFL after the 2010 season, Brett Favre has remained in the limelight.
The Hall of Famer continues to discuss his health and concerns for other past and present players’ physical wellbeing. Favre has repeatedly openly discussed the many head injuries that he suffered throughout his NFL career.
The 51-year-old voiced in April 2018 that he believes he may have suffered “thousands” of undocumented concussions in his nearly two-decade career. He has stated that his memory isn’t what it once was, making him wonder if he has any signs of Chronic traumatic encephalopathy (CTE).
“I feel as though I’m lucky, to this point, but…I find that my short-term memory, someone I met six months ago, it has gotten a lot worse,” he said in 2018, according to The Washington Post. “Simple words that would normally come out easy in a conversation, I’ll stammer.”
His personal struggles have only further fueled his desire to help those dealing with any head injuries. All that has guided Favre to keenly invest with the hopes of revolutionizing concussion treatment.
Brett Favre is investing to revolutionize concussion treatment
Over the years, Brett Favre’s efforts advocating for help with head injuries continue to increase steadily.
The former Green Bay Packers great has taken that up another notch with his latest venture. During an interview on OX Business’ “Kennedy” on Monday, Favre revealed that he’s an investor in Prevacus, a pharmaceutical company working to develop a concussion medication called Prevasol that is aimed toward preventing CTE.
“Concussions are going to happen, regardless of how good the helmets are,” Favre explained. “Spending more resources and time on prevention, rather than some type of treatment, is where [the NFL is] lacking.”
Prevacus president and founder Dr. Jacob Vanlandingham voiced that Prevasol is used to cut down the long-term damage after a concussion.
The medication is taken through a nasal spray that repairs nerves and helps cell growth. The drug has only started to enter the first phase of human trials. The expectation is that phase one tests will be completed this year.
Although it’s only the first step in the process, the medication could potentially play a pivotal part in the fight toward preventing CTE.
NFL concussions cases continue to decrease
Over the last decade, the NFL has become engulfed with concussion issues.
Things did take a positive step forward in 2020 despite the continued problems. According to Fox Sports, Jeff Miller, NFL executive vice president of communications, public affairs and policy, stated last week that the 2020 season marked the third year that the number of concussions decreased.
There remains no one-stop solution to treating concussions, but the injury’s lowered occurrence rate is encouraging news. Over the last several years, the NFL has taken steps toward helping treat and prevent these head injuries.
The league continues to utilize helmets that provide a better brace for impact to the head. They have also put instituted a more structured concussion protocol system.
The NFL will continue to deal with concussions due to the nature of the game, but there is plenty of ground to cover to one day appropriately treat the injury and prevent long-term brain damage.